Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Edinburgh, United Kingdom
Countries of investment
  • United Kingdom
Investment stages
  • Seed
  • Series A
Industries
  • MedTech
  • Digital Health
About
Archangels is an investment network based in Scotland that specializes in backing early-stage technology and life-science ventures. They provide capital, but equally important is their hands-on support. By offering mentorship, strategic advice, and access to a network of experienced professionals, Archangels helps founders build robust operations and unlock additional funding sources for later-stage development. The firm targets ventures with strong IP and high potential for long-term success.
Min check size
$100K
Max check size
$20M
Fund size
NPS

Investment Thesis

Archangels’ investment thesis is based on backing Scottish founders building innovative technology and life-science companies with defensible IP and export potential. It leverages an experienced angel investor base to provide not only equity but also strategic mentorship and board-level engagement. The firm prioritizes ventures with scalable models and credible exit pathways, ensuring a blend of financial and social impact for Scotland’s innovation ecosystem.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Experienced angel investors and venture capitalists with a strong track record in tech and life sciences, focusing on early-stage high growth businesses.

Archangels Contacts Information

Primary contact

Secondary contact

Team

Adam Stokes-Academic in residence

Andrew Sealey- Member Of The Board

Dan McKiddie- Investment ManagerDavid Ovens- Joint Managing Director

Ian Macleod- Chair

Lindsay Miller- Office Manager

Maureen Kinsler-Member Of The Board

Mike MacPhee- Member Of The Board

Neil Cunningham- Member Of The Board

Niki McKenzie-Joint Managing Director

Sarah Hardy- Director

Head of New Investments

Shaolei McKie- Senior Investment Manager

Portfolio

CALCiViS

NCTech

Optoscribe

Reactec

ZoneFox

iGii

Administrate

Cytomos

BDD Pharma

BioCaptiva

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp